🧠 Food for thought

Implications, context, and why it matters.

South Korea’s patent acceleration is a deliberate, multi-year strategy

• The new “ultra-fast” track fits into a longer government push to speed patent review.
• It follows a 2025 effort that widened expedited examination to biotech, along with other advanced technologies such as AI, and reorganized the Korean Intellectual Property Office (KIPO) into five specialized biotech divisions with 120 examiners 1. A 2026 plan adds 34 examiners and aims to cut the average wait to 14 months 2.
• AI and advanced biotech sit at the center because officials estimate annual growth around 30% and 10%. They also see a typical wait near 15 months as a competitive drag 3.
• A one-month initial result sets a steep pace compared with other patent offices. The U.S. “Track One” program averages about 4.5 months, while Europe often takes 3 to 5 years 4.

Faster patents can be a strategic weapon for Korean startups

• For startups, a quicker decision can support fundraising and partner talks.
• An initial examination result in one month lets early-stage firms share clearer IP progress than a pending application on a standard timeline. That can strengthen credibility with investors and corporate partners 5.
• A fast-granted Korean patent may also speed reviews abroad through the Patent Prosecution Highway (PPH), a system that lets one country’s patent office fast-track review based on positive results from another 4.
• The policy also serves as a government push for a “startup boom,” aiming to help national champions in priority sectors move faster than rivals 5.